Holdings in Company

RNS Number : 5489Y

Arix Bioscience Plc

06 March 2017

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

           

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii				ARIX BIOSCIENCE PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights					X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii		Takeda Ventures, Inc.
4. Full name of shareholder(s)  (if different from 3.):iv
5. Date of the transaction and date on which the threshold is crossed or reached: v		17/02/2017
6. Date on which issuer notified:		02 March 2017
7. Threshold(s) that is/are crossed or reached: vi, vii		5%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

%of voting rightsx

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares GB00BD045074

0.00

0.00

4,830,917

4,830,917

5.4%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

N/A

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

4,830,917

5.4%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:		none
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name:	Michael Martin, Ph.D.
15. Contact telephone number:	[phone]

Note: Annex should only be submitted to the FCA not the issuer

Annex: Notification of major interests in sharesxxii

A: Identity of the persons or legal entity subject to the notification obligation
Full name (including legal form of legal entities)	Takeda Ventures, Inc.
Contact address (registered office for legal entities)	435 Tasso Street, Suite 300 Palo Alto, CA 94301 USA
Phone number & email	Phone: [phone] E-mail: [e-mail]
Other useful information (at least legal representative for legal persons)

B: Identity of the notifier, if applicable
Full name	Michael Martin, Ph.D.
Contact address	435 Tasso Street, Suite 300 Palo Alto, CA 94301 USA
Phone number & email	Phone: [phone]
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)	President

C: Additional information

For notes on how to complete form TR-1 please see the FCA website.

 

END

 

 

HOLUGUQAWUPMPGA